Market closedADR

AstraZeneca/$AZN

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About AstraZeneca

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.

Ticker

$AZN
Trading on

Industry

Pharmaceuticals

Employees

89,900

AstraZeneca Metrics

BasicAdvanced
$197B
Market cap
15.37
P/E ratio
$4.15
EPS
0.18
Beta
$1.46
Dividend rate
1.54%
Dividend yield
$197B
0.18
$87.01
$60.47
6M
$1.46
0.932
0.713
73.584
77.473
71.25%
10.12%
8.50%
16.66%
15.373
1.931
3.82
-7.84
14.398
2.28%
1.54%
13.81%
9.79%
15.99%
56.50%
1.98%

What the Analysts think about AstraZeneca

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for AstraZeneca stock.

AstraZeneca Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

AstraZeneca Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AZN

$

Sign up or log in to buy
Capital at risk
Market closedADR

Upcoming events

No upcoming events

FAQs

What’s the current market cap for AstraZeneca stock?

AstraZeneca (AZN) has a market cap of $197B as of November 21, 2024.

What is the P/E ratio for AstraZeneca stock?

The price to earnings (P/E) ratio for AstraZeneca (AZN) stock is 15.37 as of November 21, 2024.

Does AstraZeneca stock pay dividends?

Yes, the AstraZeneca (AZN) stock pays dividends to shareholders. As of November 21, 2024, the dividend rate is $1.455 and the yield is 1.54%. AstraZeneca has a payout ratio of 71.25% on a trailing twelve-month basis.

When is the next AstraZeneca dividend payment date?

The next AstraZeneca (AZN) dividend payment date is unconfirmed.

What is the beta indicator for AstraZeneca?

AstraZeneca (AZN) has a beta rating of 0.18. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.